Molecular impact of clenbuterol and isometric strength training on rat EDL muscles

Pflugers Archiv European Journal of Physiology

Volumn 453, Issue 4, 2007, Pages 497-507

  Mounier, Rémi ^a   Cavalié, Hélian ^a   Lac, Gérard ^a   Clottes, Eric ^b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

2agonist; Fibre type; Gene regulation; Glycolytic metabolism; Phenotype reversion

Indexed keywords

CITRATE SYNTHASE; CLENBUTEROL; CREATINE KINASE; GLUCOSE TRANSPORTER 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEXOKINASE; LACTATE DEHYDROGENASE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; SODIUM CHLORIDE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MODIFICATION; ENZYME SPECIFICITY; EXTENSOR DIGITORUM LONGUS MUSCLE; MALE; MUSCLE HYPERTROPHY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TRAINING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; BODY WEIGHT; CITRATE (SI)-SYNTHASE; CLENBUTEROL; CREATINE KINASE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); GLYCOLYSIS; HEXOKINASE; INSULIN-LIKE GROWTH FACTOR I; ISOMETRIC CONTRACTION; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; PHYSICAL CONDITIONING, ANIMAL; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS;

EID: 33845796947     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-006-0122-1     Document Type: Article

References (41)

1. Anderson G, Wilkins E (1997) A trial of clenbuterol in bronchial asthma. Thorax 32:717-719
2. Awede BL, Thissen JP, Lebacq J (2002) Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab 282:E31-E37
3. Benovic JL (2002) Novel beta2-adrenergic receptor signaling pathways. J Allergy Clin Immunol 110:S229-S235
4. Bertin E, Ruiz JC, Mourot J, Peiniau P, Portha B (1998) Evaluation of dual-energy X-ray absorptiometry for body-composition assessment in rats. J Nutr 128:1550-1554
5. Bonen A (2001) The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. Eur J Appl Physiol 86:6-11
6. Cavalié H, Horcajada-Molteni MN, Lebecque P, Avicco MJ, Coxam V, Lac G, Barlet JP (2003) Progressive isometric force training and bone mass in rats. J Musculoskelet Neuronal Interact 3:47-52
7. Cavalié H, Lac G, Lebecque P, Chanteranne B, Davicco MJ, Barlet JP (2002) Influence of clenbuterol on bone metabolism in exercised or sedentary rats. J Appl Phys 93:2034-2037
8. Cavalié H, Mounier R, Clottes E, Bricout V, Lac G (2004) Clenbuterol treatment differently affects muscle in exercised or sedentary rats. J Exerc Physiol 7:111-120
9. Clarkson PM, Thompson HS (1997) Drugs and sport. Research findings and limitations. Sports Med 24:366-384
10. Delbeke FT, Desmet N, Debackere M (1995) The abuse of doping agents in competing body builders in Flanders (1988-1993). Int J Sports Med 16:66-70
11. Herrera NM Jr, Zimmerman AN, Dykstra DD, Thompson LV (2001) Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats. Arch Phys Med Rehabil 82: 930-934
12. Joseph J, Cruz-Sanchez FF, Carreras J (1996) Enolase activity and isoenzyme distribution in human brain regions and tumors. J Neurochem 66:2484-2490
13. Juel C, Halestrap AP (1999) Lactate transport in skeletal musclerole and regulation of the monocarboxylate transporter. J Physiol 517:633-642
14. Kandus J, Salat D (1987) Treatment of bronchial obstruction in asthma. Bull Eur Physiopathol Respir 23(Suppl 10):S103-S105
15. Kitaura T, Tsunekawa N, Hatta H (2001) Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol. J Appl Phys 91:85-90
16. Lac G, Cavalié H (1999) A rat model of progressive isometric strength training. Arch Physiol Biochem 107:144-151
17. Lynch GS, Hayes A, Campbell SP, Williams DA (1996) Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers. J Appl Phys 81:1610-1618
18. Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ (1987) The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci Rep 7:143-149
19. Megeney LA, Neufer PD, Dohm GL, Tan MH, Blewett CA, Elder GC, Bonen A (1993) Effects of muscle activity and fiber composition on glucose transport and GLUT-4. Am J Physiol 264:E583-E593
20. Mitchell GA, Dunnavan G (1998) Illegal use of beta-adrenergic agonists in the United States. Anim Sci 76:208-211
21. Moore NG, Pegg GG, Sillence MN (1994) Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am J Physiol 267:E475-E478
22. Mueckler M (1994) Facilitative glucose transporters. Eur J Biochem 219:713-725
23. Navegantes LC, Machado CR, Resano NM, Migliorini RH, Kettelhut IC (2003) Beta2-agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle. Br Poult Sci 44:149-154
24. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC (2001) Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281:E449-E454
25. Nials AT, Coleman RA, Johnson M, Magnussen H, Rabe KF, Vardey CJ (1993) Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol 110:1112-1116
26. Perry H (1993) Clenbuterol: a medal in tablet form? Br J Sports Med 27:141
27. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ (2003) Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci 44:1305-1311
28. Prather ID, Brown DE, North P, Wilson JR (1995) Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exerc 27: 1118-1121
29. Rajab P, Fox J, Riaz S, Tomlinson D, Ball D, Greenhaff PL (2000) Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol Regul Integr Comp Physiol 279:R1076-R1081
30. Reeds PJ, Hay SM, Dorwood PM, Palmer RM (1986) Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br J Nutr 56:249-258
31. Rossignol F, Solares M, Balanza E, Coudert J, Clottes E (2003) Expression of lactate dehydrogenase A and B genes in different tissues of rats adapted to chronic hypobaric hypoxia. J Cell Biochem 89:67-79
32. Rossignol F, Vaché C, Clottes E (2002) Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. Gene 299: 135-140
33. Rothwell N, Stock MJ (1985) Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice. Biosci Rep 5:755-760
34. Spann C, Winter ME (1995) Effect of clenbuterol on athletic performance. Ann Pharmacother 29:75-77
35. Srere PA (1974) Controls of citrate synthase activity. Life Sci 15:1695-1710
36. Stuart CA, Wen G, Gustafson WC, Thompson EA (2000) Comparison of GLUT1, GLUT3, and GLUT4 mRNA and the subcellular distribution of their proteins in normal human muscle. Metabolism 49:1604-1609
37. Talmadge RJ, Roy RR (1993) Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75:2337-2340
38. Tsao TS, Li J, Chang KS, Stenbit AE, Galuska D, Anderson JE, Zierath JR, McCarter RJ, Charron MJ (2001) Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity. FASEB J 15:958-969
39. Waterfield CJ, Jairath M, Asker DS, Timbrell JA (1995) The biochemical effects of clenbuterol: with particular reference to taurine and muscle damage. Eur J Pharmacol 293:141-149
40. Wilson MC, Meredith D, Halestrap AP (2002) Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. J Biol Chem 277:3666-3672
41. Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG (1999) Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ Res 85:1092-1100